Targeting vascular and leukocyte communication in angiogenesis, inflammation and fibrosis

Cites (252)

Items 201–251 of 251

1. Development of Drugs to Target Interactions Between Leukocytes and Endothelial Cells and Treatment Algorithms for Inflammatory Bowel Diseases
   Silvio Danese, Julián Panés · 2014 · Gastroenterology
2. Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
   Francesco Dituri, Antonio Mazzocca, Fernando Juan Peidrò, Patrizia Papappicco, Isabel Fabregat, Flavia De Santis, Angelo Paradiso, Carlo Sabbà, Gianluigi Giannelli · 2013 · PLoS ONE
3. BIBF 1120 (Nintedanib), a Triple Angiokinase Inhibitor, Induces Hypoxia but not EMT and Blocks Progression of Preclinical Models of Lung and Pancreatic Cancer
   Bercin Kutluk Cenik, Katherine T. Ostapoff, David E. Gerber, Rolf A. Brekken · 2013 · Molecular Cancer Therapeutics
4. Intussusceptive angiogenesis: pillars against the blood flow
   Beata Styp‐Rekowska, Ruslan Hlushchuk, Axel Radlach Pries, Valentin Djonov · 2011 · Acta Physiologica
5. Imatinib disrupts lymphoma angiogenesis by targeting vascular pericytes
   Jia Ruan, Min Luo, Chunjie Wang, Lei Fan, Shao Ning Yang, Mariano Cárdenas, Huimin Geng, John Paul Leonard, Ari M. Melnick, Leandro C. A. Cerchietti et al. · 2013 · Blood
6. Maraviroc
   Caroline M. Perry · 2010 · Drugs
7. Building blood vessels—stem cell models in vascular biology
   Lars Jakobsson, Johan Kreuger, Lena Claesson‐Welsh · 2007 · The Journal of Cell Biology
8. Endothelial LSP1 is involved in endothelial dome formation, minimizing vascular permeability changes during neutrophil transmigration in vivo
   Björn Petri, Jaswinder Kaur, Elizabeth M. Long, Hang Li, Sean A. Parsons, Stefan Butz, Mia Phillipson, Dietmar Vestweber, Kamala D. Patel, Stephen M. Robbins et al. · 2010 · Blood
9. GAP JUNCTION INTERCELLULAR COMMUNICATION DURING LYMPHOCYTE TRANSENDOTHELIAL MIGRATION
   Ernesto Oviedo‐Orta, Rachel J. Errington, W. Howard Evans · 2002 · Cell Biology International
10. MK-2461, a Novel Multitargeted Kinase Inhibitor, Preferentially Inhibits the Activated c-Met Receptor
    Bo‐Sheng Pan, Grace K.Y. Chan, Mélissa Chénard, An Chi, Lenora J. Davis, Sujal V. Deshmukh, W. Wayt Gibbs, Susana Gil, Gaozhen Hang, Harold Hatch et al. · 2010 · Cancer Research
11. Site-Specific Inhibition of Glomerulonephritis Progression by Targeted Delivery of Dexamethasone to Glomerular Endothelium
    Sigrídur A. Ásgeirsdóttir, Jan A. A. M. Kamps, Hester I. Bakker, Peter J. Zwiers, Peter Heeringa, Karen van der Weide, Harry van Goor, Arjen H. Petersen, Henriëtte W. M. Morselt, Henk E. Moorlag et al. · 2007 · Molecular Pharmacology
12. Inhibition of delta-like-4-mediated signaling impairs reparative angiogenesis after ischemia
    Al Haj Zen, Ayman, Oikawa, Atsuhiko, Bazan-Peregrino, Miriam, Meloni, Marco, Emanueli, Costanza, Madeddu, Paolo · 2010 · Circulation Research
13. Antagonizing the α4β1 Integrin, but Not α4β7, Inhibits Leukocytic Infiltration of the Central Nervous System in Rhesus Monkey Experimental Autoimmune Encephalomyelitis
    Krista G. Haanstra, Sam Hofman, Dave M. Lopes Estêvão, Erwin L. A. Blezer, Jan Bauer, Li-Li Yang, Timothy L. Wyant, Vilmos Csizmadia, Bert A. ‘t Hart, Eric Robert Fedyk · 2013 · The Journal of Immunology
14. TGF-β-Neutralizing Antibody 1D11 Enhances Cytarabine-Induced Apoptosis in AML Cells in the Bone Marrow Microenvironment
    Yoko Tabe, Yue Xi Shi, Zhihong Zeng, Linhua Jin, Masato Shikami, Yasuhito Hatanaka, Takashi Miida, Frank James Hsu, Michael Andreeff, Marina Y Konopleva · 2013 · PLoS ONE
15. Vedolizumab, a monoclonal antibody to the gut homing α4β7 integrin, does not affect cerebrospinal fluid T-lymphocyte immunophenotype
    Catherine E. Milch, Timothy L. Wyant, Jing Xu, Asit Parikh, Whitney Kent, Irving H. Fox, Joseph R. Berger · 2013 · Journal of Neuroimmunology
16. Intraperitoneal recombinant gamma-interferon in patients with recurrent ascitic ovarian carcinoma: modulation of cytotoxicity and cytokine production in tumor-associated effectors and of major histocompatibility antigen expression on tumor cells.
    Paola Allavena, Fedro Alessandro Peccatori, Daniela Maggioni, Annalaura Erroi, Marina Sironi, Nicoletta Colombo, Andrea Alberto Lissoni, Andrew R. Galazka, W. Meiers, Costantino Mangioni · 1990 · PubMed
17. Transendothelial Migration Enables Subsequent Transmigration of Neutrophils through Underlying Pericytes
    Chantal E. Ayres-Sander, Holly M. Lauridsen, Cheryl L. Maier, Parid Sava, Jordan S. Pober, Anjelica L. Gonzalez · 2013 · PLoS ONE
18. Exo70 Isoform Switching upon Epithelial-Mesenchymal Transition Mediates Cancer Cell Invasion
    Hezhe Lu, Jianglan Liu, Shujing Liu, Jingwen Zeng, Deqiang Ding, Russ P. Carstens, Yu‐Sheng Cong, Xiaowei Xu, Wei Guo · 2013 · Developmental Cell
19. H-Ras transfers from B to T cells via tunneling nanotubes
    Nir Rainy, David Chetrit, Vincent Rouger, Helly Vernitsky, Oded Rechavi, Didier Marguet, Itamar Goldstein, Marcelo Ehrlich, Yoel Kloog · 2013 · Cell Death and Disease
20. Platelets in Angiogenesis
    Johannes Patzelt, Harald F. Langer · 2012 · Current Vascular Pharmacology
21. The Wingless homolog Wnt5a stimulates phagocytosis but not bacterial killing
    George Maiti, Debdut Naskar, Malini Sen · 2012 · Proceedings of the National Academy of Sciences
22. Anti‐PDGF‐B monoclonal antibody reduces liver fibrosis development
    Shinji Ogawa, Takashi Ochi, Hideaki Shimada, Kazuyuki Inagaki, Isami Fujita, Aisuke Nii, Mark A. Moffat, Madan Katragadda, Bernard N. Violand, Robert H. Arch et al. · 2010 · Hepatology Research
23. Inhibition of Notch signaling induces extensive intussusceptive neo-angiogenesis by recruitment of mononuclear cells
    Ivanka Istalianova Dimova, Ruslan Hlushchuk, Andrew Ndegwa Makanya, Beata Styp‐Rekowska, Raluca Amalia Ceauşu, Stefanie Flückiger-Mangual, Sonja Lang, David Semela, Ferdinand A. C. le Noble, Suvro Chatterjee et al. · 2013 · Angiogenesis
24. Efficacy and Side Effects of Natalizumab Therapy in Patients with Multiple Sclerosis
    Robert Hoepner, Simon Faissner, Anke Salmen, Ralf Gold, Andrew Chan · 2014 · Journal of Central Nervous System Disease
25. Management of treatment-associated toxicites of anti-angiogenic therapy in patients with brain tumors
    Terri S. Armstrong, Patrick Yung Wen, M. R. Gilbert, David Schiff · 2012 · Neuro-Oncology
26. Macrophage Wnt-Calcineurin-Flt1 signaling regulates mouse wound angiogenesis and repair
    James A. Stefater, Sujata Rao, Katherine Young Bezold Lamm, Alfred C. Aplin, Roberto Francesco Nicosia, Jeffrey W. Pollard, Napoleone Ferrara, Richard A. Lang · 2013 · Blood
27. Wnt5a stimulates chemotactic migration and chemokine production in human neutrophils
    Young Su Jung, Ha Young Lee, Sang Doo Kim, Joon Seong Park, Jung Kuk Kim, Pann‐Ghill Suh, Yoe‐Sik Bae · 2013 · Experimental & Molecular Medicine
28. Ophthalmology 1 Age-related macular degeneration
    Laurence Shen Lim, Paul Mitchell, Johanna M. Seddon, Frank Gerhard Holz, Tien Yin Wong · 2012
29. An oligonucleotide decoy for Stat3 activates the immune response of macrophages to breast cancer
    Zhengkui Sun, Zhenxiang Yao, Shengchun Liu, Hua Tang, Yan Xiong · 2006 · Immunobiology
30. Neutralizing Nanobodies Targeting Diverse Chemokines Effectively Inhibit Chemokine Function
    Christophe Blanchetot, Dennis Verzijl, Azra Mujić-Delić, Leontien Bosch, Louise Rem, Rob Leurs, C. Theo Verrips, Michael John Saunders, Hans de Haard, Martine J. Smit · 2013 · Journal of Biological Chemistry
31. PHD2 regulates arteriogenic macrophages through TIE2 signalling
    Alexander Hamm, Lorenzo Veschini, Yukiji Takeda, Sandra Costa, Estelle Delamarre, Mario Leonardo Squadrito, Anne‐Theres Henze, Mathias Wenes, Jens Serneels, Ferdinando Pucci et al. · 2013 · EMBO Molecular Medicine
32. Cardiac to cancer: Connecting connexins to clinical opportunity
    Christina L. Grek, Joshua Matthew Rhett, Gautam S. Ghatnekar · 2014 · FEBS Letters
33. Combined VEGF and CXCR4 antagonism targets the GBM stem cell population and synergistically improves survival in an intracranial mouse model of glioblastoma
    Amy K. Barone, Rajarshi Sengupta, Nicole M. Warrington, Erin Smith, Patrick Yung Wen, Rolf A. Brekken, Bárbara Romagnoli, Garry J. Douglas, Éric Chevalier, Michael Bauer et al. · 2014 · Oncotarget
34. Screening chelating inhibitors of HIF-prolyl hydroxylase domain 2 (PHD2) and factor inhibiting HIF (FIH)
    Shannon C. Flagg, Cristina B. Martin, Cornelius Y. Taabazuing, Breanne E. Holmes, Michael J. Knapp · 2012 · Journal of Inorganic Biochemistry
35. Targeting chemokines and chemokine receptors with antibodies
    Alex Klarenbeek, David Maussang, Christophe Blanchetot, Michael John Saunders, Sebastian P. van der Woning, Martine J. Smit, Hans de Haard, Erik G. Hofman · 2012 · Drug Discovery Today Technologies
36. Correction: Differential Inhibition of the TGF-β Signaling Pathway in HCC Cells Using the Small Molecule Inhibitor LY2157299 and the D10 Monoclonal Antibody against TGF-β Receptor Type II
    Francesco Dituri, Antonio Mazzocca, Joan Fernando, Patrizia Papappicco, Isabel Fabregat, Flavia De Santis, Angelo Paradiso, Carlo Sabbà, Gianluigi Giannelli · 2013 · PLoS ONE
37. Metformin-Mediated Bambi Expression in Hepatic Stellate Cells Induces Prosurvival Wnt/β-Catenin Signaling
    Nanthakumar Subramaniam, Mara H. Sherman, Renuka Rao, Caroline L Wilson, Sally Coulter, Annette R. Atkins, Ronald M. Evans, Christopher Liddle, Michael Downes · 2012 · Cancer Prevention Research
38. Delta-like 4 inhibits choroidal neovascularization despite opposing effects on vascular endothelium and macrophages
    Serge Camelo, William Raoul, Sophie Lavalette, Bertrand Calippe, Brunella Cristofaro, Olivier Levy, Marianne Houssier, Eric Sulpice, Laurent Jonet, Christophe Klein et al. · 2012 · Angiogenesis
39. Citrullination of TNF-α by peptidylarginine deiminases reduces its capacity to stimulate the production of inflammatory chemokines
    Eva A. V. Moelants, Anneleen Mortier, Karolien Grauwen, Isabelle Ronsse, Jo Van Damme, Paul Proost · 2012 · Cytokine
40. Vascular-homing peptides for targeted drug delivery and molecular imaging: Meeting the clinical challenges
    Nunzia D’Onofrio, Michele Caraglia, Anna Grimaldi, Raffaele Marfella, Luigi Servillo, Giuseppe Paolisso, Maria Luisa Balestrieri · 2014 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
41. The exocyst and regulatory GTPases in urinary exosomes
    Maria F. Chacon-Heszele, Soo Young Choi, Xiaofeng Zuo, Jeong‐In Baek, Chris Ward, Joshua H. Lipschutz · 2014 · Physiological Reports
42. Connexin45 Regulates Endothelial-Induced Mesenchymal Cell Differentiation Toward a Mural Cell Phenotype
    Jennifer Shea‐Ying Fang, Cuiping Dai, David T. Kurjiaka, Janis M. Burt, Karen K. Hirschi · 2012 · Arteriosclerosis Thrombosis and Vascular Biology
43. Citrullination and Proteolytic Processing of Chemokines by Porphyromonas gingivalis
    Eva A. V. Moelants, G. Loozen, Anneleen Mortier, Erik Martens, Ghislain Opdenakker, Danuta Mizgalska, Borys Szmigielski, Jan Potempa, Jo Van Damme, Wim Teughels et al. · 2014 · Infection and Immunity
44. Anti-angiogenic drug discovery: lessons from the past and thoughts for the future
    Jessie M. Wu, Carolyn A. Staton · 2012 · Expert Opinion on Drug Discovery
45. Kinase Inhibition — A New Approach to the Treatment of Rheumatoid Arthritis
    David A. Fox · 2012 · New England Journal of Medicine
46. Rescue from acute neuroinflammation by pharmacological chemokine-mediated deviation of leukocytes
    Nele Berghmans, Hubertine Heremans, Sandra Li, Erik Martens, Patrick Matthys, Lydia M. Sorokin, Jo Van Damme, Ghislain Opdenakker · 2012 · Journal of Neuroinflammation
47. Interference with Glycosaminoglycan-Chemokine Interactions with a Probe to Alter Leukocyte Recruitment and Inflammation In Vivo
    Sandra Li, Ulrika S. Pettersson, Bart Hoorelbeke, Elżbieta Kołaczkowska, Katrien Schelfhout, Erik Martens, Paul Kubes, Jo Van Damme, Mia Phillipson, Ghislain Opdenakker · 2014 · PLoS ONE
48. Tension in the vasculature
    Andrew V. Benest, Hellmut G. Augustin · 2009 · Nature Medicine
49. For Organ Transplant Recipients, Cancer Threatens Long-term Survival
    Kelley Ross · 2007 · JNCI Journal of the National Cancer Institute
50. 370 AJM300, an Oral α4 Integrin Antagonist, for Active Ulcerative Colitis: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2A Study
    Mamoru Watanabe, Naoki Yoshimura, Satoshi Motoya, Keiichi Tominaga, Ryuichi Iwakiri, Kenji Watanabe, Toshifumi Hibi∥ · 2014 · Gastroenterology
51. Untitled work
    2000 · 10.1002/1097-0177(200007)218:3